ReWalk Robotics (NASDAQ: RWLK) and Invacare (NYSE:IVC) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, valuation, profitability, analyst recommendations, earnings and dividends.
Risk & Volatility
Get ReWalk Robotics alerts:
ReWalk Robotics has a beta of 0.56, indicating that its share price is 44% less volatile than the S&P 500. Comparatively, Invacare has a beta of 2.52, indicating that its share price is 152% more volatile than the S&P 500.
Invacare pays an annual dividend of $0.05 per share and has a dividend yield of 0.3%. ReWalk Robotics does not pay a dividend. Invacare pays out -2.6% of its earnings in the form of a dividend.
Valuation & Earnings
This table compares ReWalk Robotics and Invacare’s top-line revenue, earnings per share (EPS) and valuation.
Top Medical Stocks To Invest In 2019: Odyssey Marine Exploration Inc.(OMEX)
- [By Money Morning Staff Reports]
After looking at this week’s penny stock gainers, we’ll give you that leg up with one of our top-rated penny stocks from our proprietary stock ranking system…
Penny Stock Current Share Price (March 26) Last Week’s Gain
Cartesian Inc. (OTCMKTS: CRTN) $0.39 170.69%
Odyssey Marine Exploration Inc. (Nasdaq: OMEX) $8.76 135.90%
iFresh Inc. (Nasdaq: IFMK) $8.25 64.64%
China Auto Logistics Inc. (Nasdaq: CALI) $4.68 47.43%
National American University Holdings Inc. (Nasdaq: NAUH) $1.20 39.29%
Document Security Systems Inc. (NYSE: DSS) $1.58 33.91%
Blonder Tongue Labs Inc. (NYSE: BDR) $0.77 33.90%
CareDx Inc. (Nasdaq: CDNA) $7.49 29.88%
Mediwound Ltd. (Nasdaq: MDWD) $5.10 26.51%
New York & Co. Inc. (NYSE: NWY) $3.37 26.35%
Don’t Miss This Shot at a $78,000 Windfall: This tiny firm is about to make the entire world wire-free. As its game-changing technology revolutionizes the global power structure, its stock could hand investors a massive return. Learn more…
- [By Joseph Griffin]
News stories about Odyssey Marine Exploration (NASDAQ:OMEX) have trended somewhat positive recently, according to Accern. The research firm identifies positive and negative news coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Odyssey Marine Exploration earned a media sentiment score of 0.01 on Accern’s scale. Accern also assigned media coverage about the business services provider an impact score of 46.3184749361846 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.
- [By Joseph Griffin]
Kenon (NYSE: KEN) and Odyssey Marine Exploration (NASDAQ:OMEX) are both small-cap utilities companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, valuation, analyst recommendations, earnings, institutional ownership, risk and dividends.
Top Medical Stocks To Invest In 2019: Kronos Worldwide Inc(KRO)
- [By Maxx Chatsko]
Shares ofKronos Worldwide (NYSE:KRO) plunged on Wednesday after the company announced first-quarter 2018 results. The titanium dioxide manufacturer reported strong growth compared to the year-ago period thanks to the continued surge in selling prices. Revenue was up 16% and net income nearly doubled relative to the first quarter of 2017. How can Wall Street be displeased with that?
Top Medical Stocks To Invest In 2019: Netflix, Inc.(NFLX)
- [By Jon C. Ogg]
Netflix, Inc. (NASDAQ: NFLX) was down over 6.6% at $299.00 late on Tuesday, but that’s now down 10% from the recent all-time high of $333.98. People definitely aren’t giving up on Netflix, but when leaders sell-off it’s hard to have a forward P/E of 120 times current year expected earnings.
- [By Anders Bylund]
Shares of Netflix Inc. (NASDAQ:NFLX) jumped as much as 5.6% higher on Wednesday, thanks to a glowing research note from Goldman Sachs. As of 3:50 p.m. EDT, the stock had seen more market-moving news before cooling down to a 4.1% gain.
- [By Max Byerly]
Netflix (NASDAQ:NFLX) had its target price hoisted by research analysts at Piper Jaffray from $360.00 to $367.00 in a note issued to investors on Tuesday. Piper Jaffray’s price objective would suggest a potential upside of 19.24% from the company’s previous close.
- [By Natalie Walters]
Disney (NYSE:DIS)has taken some flak recently due toNetflix (NASDAQ:NFLX)taking its place as the most valuable media company in the world.
Netflix is currently at a $165 billion market cap, just topping Disney’s $156 billion figure. It’s a sign of the streaming times, but it doesn’t mean Disney is done having its presence felt in the space. Next year the House of Mouse will launch its own over-the-top (OTT) streaming service, and it already has a number of current and potential advantages that will help it compete with Netflix. Here are three:
- [By Motley Fool Staff]
One company that everyone has their eyes on in more ways than one is Netflix(NASDAQ:NFLX), which continued to build its customer base faster than analysts expected it could last quarter. It also increased revenue by more than 40% — so, yes, unlike most companies. Its growth is accelerating as it gets larger. The guys weigh in, and consider the case for investing in it now.
- [By Joseph Griffin]
Traders sold shares of Netflix, Inc. (NASDAQ:NFLX) on strength during trading on Monday. $760.29 million flowed into the stock on the tick-up and $824.52 million flowed out of the stock on the tick-down, for a money net flow of $64.23 million out of the stock. Of all equities tracked, Netflix had the 13th highest net out-flow for the day. Netflix traded up $6.75 for the day and closed at $398.18